Send me real-time posts from this site at my email
Motley Fool

Abbott Labs Recalls Some Catheters Due to Possible Defects

The U.S. Food and Drug Administration stated on Wednesday that some lots of two catheters models sold by Abbott Laboratories (NYSE: ABT) needed to be recalled due to potentially severe safety issues. The agency defined them as Class I recalls, the most serious type, and it warned that using these devices could cause serious injury or even death.

The models in question are the NC Trek RX and the NC Traveler RX coronary dilation catheters with balloon diameters of 4.0mm, 4.5mm, and 5.0mm. The issue is that the balloons may not deflate the way they are supposed to. The problem seems to have been caused by overexposure to heat during the manufacturing process, which weakens the material near the balloon.

Image source: Getty Images.

"Use of these devices may cause serious adverse health consequences, such as prolonged cardiac ischemia (reduced blow flow to the heart), air embolism, thrombosis (clot in the artery), myocardial infarction (heart attack), and additional surgery that could lead to post-operative complications, including death," warned the agency in an official statement.

Additional details

The recall applies to 13,891 devices that were distributed between August 2019 and January 2020. So far, there have been 13 complaints recorded relating to the problem, with one confirmed death.

This isn't the first time there's been an issue with Abbott's catheters. Back in 2017, the www.fool.com/investing/how-to-invest-in-healthcare-stocks.as..." target="_blank">healthcare giant warned hospitals and healthcare professionals to stop using a number of its catheters due to problems with the balloon sheath. As many as 449,661 catheters were identified as potentially being defective at the time.

10 stocks we like better than Abbott Laboratories
When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade, Motley Fool Stock Advisor, has tripled the market.*

David and Tom just revealed what they believe are the ten best stocks for investors to buy right now... and Abbott Laboratories wasn't one of them! That's right -- they think these 10 stocks are even better buys.

See the 10 stocks

*Stock Advisor returns as of December 1, 2019

Mark Prvulovic has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.


Source

Popular posts

Welcome!!! Is it your First time here?

What are you looking for? Select your points of interest to improve your first-time experience:

Apply & Continue